Clinical Trial Update: A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating inhaled mesenchymal progenitor cell exosomes for pulmonary infections has been suspended (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Infection

Drugs mentioned

• Mesenchymal Progenitor Cell Exosome Nebulizer

Snippet

Sponsor: Ruijin Hospital | Conditions: Drug-resistant | Phase 1, Phase 2 | Status: SUSPENDED